FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1699697260> ?p ?o ?g. }

• W1699697260 endingPage "720" @default.
• W1699697260 startingPage "712" @default.
• W1699697260 abstract "The effect of high-dose aprotinin treatment on hemostatic activation during cardiopulmonary bypass in pediatric patients having cardiac operations was investigated. Sixty patients weighing less than 10 kg undergoing cardiac operations for different types of congenital heart diseases were studied: 20 patients were treated with aprotinin 2 × 15,000 KIU/kg, 20 patients with 2 × 30,000 KIU/kg, and 20 patients without aprotinin treatment served as the control group. Different split products of fibrinogen and/or fibrin and the fibrinolytic activity on fibrin plates were measured to assess fibrinolytic activation. F1/F2 prothrombin fragments, thrombin-antithrombin III-complex, and fibrin monomers were measured to estimate thrombin activation. There was a significant dose-dependent reduction in fibrin-fibrinogen split product formation during cardiopulmonary bypass: In the high-dose aprotinin group the concentration of the split products at the end of bypass was 1.5 ± 0.6 μg/ml, compared with 3.4 ± 3.0 μg/ml in the low-dose aprotinin group and 6.7 ± 3.5 μg/ml in the control group (p < 00.5). Fibrinolytic activation on fibrin plates was also significantly reduced by aprotinin. Fibrin monomer formation was significantly diminished at the end of cardiopulmonary bypass in the high-dose group: 9.2 ± 5.2 μg/ml compared with 21.6 ± 14 μg/ml in the control group (p < 00.5). Elastase in complex with α1-protease inhibitor at the end of bypase was increased to the same amount in the three groups: 784 ± 278 ng/mL (control group), 693 ± 189 ng/ml (low-dose aprotinin), and 719 ± 270 ng/mL (high dose aprotinin) (no significant difference). Blood loss 6 hours postoperatively was significantly (p < 00.5) less in the high-dose group (99 ± 32 ml/m2) than in the control group (164 ± 87 ml/m2; low-dose group: 160 ± 106 ml/m2). These observations suggest an attenuation of hemostatic activation during cardiopulmonary bypass with less plasmin formation and, because of inhibition of contact activation, less thrombin generation with aprotinin treatment. Thus the thrombotic-thrombolytic equilibrium is kept more balanced after cardiopulmonary bypass. High-dose aprotinin treatment is recommended for pediatric patients undergoing cardiac operations." @default.
• W1699697260 created "2016-06-24" @default.
• W1699697260 creator A5029660812 @default.
• W1699697260 creator A5035296329 @default.
• W1699697260 creator A5051073073 @default.
• W1699697260 creator A5054580508 @default.
• W1699697260 creator A5055065116 @default.
• W1699697260 creator A5060783883 @default.
• W1699697260 creator A5063888339 @default.
• W1699697260 creator A5086134082 @default.
• W1699697260 date "1993-04-01" @default.
• W1699697260 modified "2023-10-11" @default.
• W1699697260 title "Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations" @default.
• W1699697260 cites W12076958 @default.
• W1699697260 cites W127580824 @default.
• W1699697260 cites W1516463094 @default.
• W1699697260 cites W192624987 @default.
• W1699697260 cites W1967298175 @default.
• W1699697260 cites W1979997485 @default.
• W1699697260 cites W1987347324 @default.
• W1699697260 cites W1993626532 @default.
• W1699697260 cites W1997068213 @default.
• W1699697260 cites W1998839443 @default.
• W1699697260 cites W2006097019 @default.
• W1699697260 cites W2009699612 @default.
• W1699697260 cites W2017118779 @default.
• W1699697260 cites W2029475717 @default.
• W1699697260 cites W2057646315 @default.
• W1699697260 cites W2063041823 @default.
• W1699697260 cites W2066599234 @default.
• W1699697260 cites W2068490498 @default.
• W1699697260 cites W2070586531 @default.
• W1699697260 cites W2078171732 @default.
• W1699697260 cites W2097908856 @default.
• W1699697260 cites W2118414830 @default.
• W1699697260 cites W2138849164 @default.
• W1699697260 cites W2156910916 @default.
• W1699697260 cites W2171389513 @default.
• W1699697260 cites W2253816243 @default.
• W1699697260 cites W2330568965 @default.
• W1699697260 cites W2341630418 @default.
• W1699697260 cites W2400328953 @default.
• W1699697260 cites W2408971219 @default.
• W1699697260 cites W2412534193 @default.
• W1699697260 cites W2414401619 @default.
• W1699697260 cites W2414469094 @default.
• W1699697260 cites W2414531805 @default.
• W1699697260 cites W2416111847 @default.
• W1699697260 cites W3021384959 @default.
• W1699697260 cites W4252145302 @default.
• W1699697260 cites W4321000856 @default.
• W1699697260 cites W95863119 @default.
• W1699697260 doi "https://doi.org/10.1016/s0022-5223(19)34198-4" @default.
• W1699697260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7682267" @default.
• W1699697260 hasPublicationYear "1993" @default.
• W1699697260 type Work @default.
• W1699697260 sameAs 1699697260 @default.
• W1699697260 citedByCount "79" @default.
• W1699697260 countsByYear W16996972602016 @default.
• W1699697260 countsByYear W16996972602019 @default.
• W1699697260 countsByYear W16996972602021 @default.
• W1699697260 countsByYear W16996972602022 @default.
• W1699697260 crossrefType "journal-article" @default.
• W1699697260 hasAuthorship W1699697260A5029660812 @default.
• W1699697260 hasAuthorship W1699697260A5035296329 @default.
• W1699697260 hasAuthorship W1699697260A5051073073 @default.
• W1699697260 hasAuthorship W1699697260A5054580508 @default.
• W1699697260 hasAuthorship W1699697260A5055065116 @default.
• W1699697260 hasAuthorship W1699697260A5060783883 @default.
• W1699697260 hasAuthorship W1699697260A5063888339 @default.
• W1699697260 hasAuthorship W1699697260A5086134082 @default.
• W1699697260 hasBestOaLocation W16996972601 @default.
• W1699697260 hasConcept C126322002 @default.
• W1699697260 hasConcept C141071460 @default.
• W1699697260 hasConcept C164705383 @default.
• W1699697260 hasConcept C203014093 @default.
• W1699697260 hasConcept C2777292125 @default.
• W1699697260 hasConcept C2777987278 @default.
• W1699697260 hasConcept C2778589496 @default.
• W1699697260 hasConcept C2778789114 @default.
• W1699697260 hasConcept C2778881276 @default.
• W1699697260 hasConcept C2779036427 @default.
• W1699697260 hasConcept C2779637338 @default.
• W1699697260 hasConcept C2780799893 @default.
• W1699697260 hasConcept C2781436528 @default.
• W1699697260 hasConcept C2910225729 @default.
• W1699697260 hasConcept C2991743468 @default.
• W1699697260 hasConcept C42219234 @default.
• W1699697260 hasConcept C54173615 @default.
• W1699697260 hasConcept C71924100 @default.
• W1699697260 hasConcept C89560881 @default.
• W1699697260 hasConceptScore W1699697260C126322002 @default.
• W1699697260 hasConceptScore W1699697260C141071460 @default.
• W1699697260 hasConceptScore W1699697260C164705383 @default.
• W1699697260 hasConceptScore W1699697260C203014093 @default.
• W1699697260 hasConceptScore W1699697260C2777292125 @default.
• W1699697260 hasConceptScore W1699697260C2777987278 @default.
• W1699697260 hasConceptScore W1699697260C2778589496 @default.

• next